NOS2 (Nitric Oxide Synthase 2)

We conclude that ET not only impairs immune surveillance but also reshapes the tumor microenvironment in favor of cancer growth. This highlights the potential role of ET in oncology and suggests that its modulation could represent a novel avenue for therapeutic intervention.

Pharmacological inhibition of LDHA with FX-11 synergized with anti-PD-L1 therapy, producing durable tumor regression. Collectively, these findings define LDHA-driven lactate metabolism as a key metabolic checkpoint in PCa immune evasion and provide a rationale for combining LDHA inhibition with immune checkpoint blockade to overcome immunotherapy resistance.

Moreover, OX40-antibody-mediated regulatory T cell (Treg) depletion potentiated NOS2+ macrophage induction. This multimodal strategy offers a promising solution to overcome the limitations of OX40 antibody monotherapy and enhance outcomes of the OX40-targeted immunotherapies.

Further investigations reveal that Gsα upregulates expression of CD86, CCR5, Il1b and Nos2, and inhibits CD206 and Il10 expression, which facilitates antitumoral activity of TAMs. Mechanistically, Gsα promotes M1 polarization of TAMs via upregulating phosphorylation of ERK, p38 and JNK in MAPK signaling pathway.

These integrated findings underscore the beneficial immune microenvironment in LTS HGG driven by specific innate and adaptive immune components. This immune signature may serve as a prognostic indicator and guide immunomodulatory therapeutic strategies for gliomas.

In this study, we proposed Fh15, a recombinant protein derived from Fasciola hepatica, as a potent immunomodulatory agent capable of attenuating the cytokine storm, improving survival, and modulating macrophage activity in a mouse model of septic shock. These findings underscore the potential of Fh15 as a novel anti-inflammatory agent, offering a promising therapeutic approach to manage endotoxemia and reduce sepsis-related mortality.

PRMT1 links NO metabolism to glioma stemness and immunosuppression by regulating stemness factors (OCT4, SOX2) and immune checkpoints (PD-L1) through NO-dependent mechanisms. PRMT1 represents a therapeutic target that could disrupt stem cell populations and remodel the immunosuppressive microenvironment.

These findings suggest a potential autophagy-mediated regulatory mechanism in RA macrophage function.Abbreviations: ATG: autophagy related; BECN1: beclin 1; IL: interleukin; LAMP1: lysosomal associated membrane protein 1; LIS: less-inflammatory synovium; MAP1LC3/LC3: microtubule sssociated protein 1 light chain 3; MFI: mean fluorescence intensity; OA: osteoarthritis; PG: phagophore; RA: rheumatoid arthritis. SQSTM1: sequestosome 1; TNF: tumor necrosis factor; WIPI2: WD repeat domain, phosphoinositide interacting 2.

CRISPR sequences from these prokaryotes show notable similarities with human miRNAs, suggesting possible indirect links to genes involved in major diseases. These preliminary findings emphasize the need for further investigation into shared sequence motifs and their functional roles in host-pathogen interactions or evolutionary biology.

Consequently, SNHG18 deficiency fosters an immunosuppressive TME and promotes PCa BM. SNHG18 expression may serve as a predictive biomarker for ICB response, offering a novel strategy to overcome immunotherapy resistance in PCa BM.

Sting activation was visualized longitudinally using 3'-deoxy-3'-[18F]-fluorothymidine ([18F]-FLT) PET, which peaked 72-96 hours after 8803 administration. In summary, 8803 combined with RT triggers distinctive antiglioma immune reactivity, facilitates BBB opening, and warrants consideration for up-front clinical trials in glioblastoma, where treatment effects can be monitored using [18F]-FLT PET imaging.

Arginine metabolism stratifies MCs into pro-tumorigenic HAS and quiescent LAS subsets; ASL-high MCs constitute a metabolically wired, highly communicating population that fuels TNBC progression and furnishes an exploitable prognostic signature. OAT, a key HAS-associated gene, promotes breast cancer aggressiveness through proliferation, survival, and invasion.